High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$2.4M
$2,423,592
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
CYTK
S
CYTOKINETICS INC
Malik Fady Ibraham
• Officer • EVP Research & Development
Sell to Cover
2026-03-09
$176,513
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP Research & Development
Sell to Cover
|
2026-03-09 | $176,513 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-09
$156,779
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-09 | $156,779 | S | Form 4 |
| CYTK |
CYTOKINETICS INC
|
CEO
Sell to Cover
|
2026-03-09 | $481,570 | S | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -19.6%
2026-03-05
$928,050
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -19.6%
|
2026-03-05 | $928,050 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Other
2026-03-05
$348,900
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Other
|
2026-03-05 | $348,900 | M | Form 4 |
|
CYTK
S
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -17.9%
2026-03-05
$680,680
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
10b5-1 SellΔOwn -17.9%
|
2026-03-05 | $680,680 | S | Form 4 |
|
CYTK
M
CYTOKINETICS INC
Callos Andrew
• Officer • EVP, Chief Commercial Officer
Other
2026-03-05
$430,430
|
||||||
| CYTK |
CYTOKINETICS INC
|
Officer • EVP, Chief Commercial Officer
Other
|
2026-03-05 | $430,430 | M | Form 4 |